New vaccines against tuberculosis. The status of current research

Infectious Disease Clinics of North America

Volumn 13, Issue 1, 1999, Pages 169-185

  Orme, I M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DNA VACCINE; RECOMBINANT VACCINE;

AUXOTROPHIC MUTANT; HUMAN; IMMUNE RESPONSE; MESENTERIC LYMPHADENITIS; MYCOBACTERIUM; NONHUMAN; OSTEITIS; REVIEW; TUBERCULOSIS;

EID: 0032933480     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70049-0     Document Type: Article

References (101)

1. S. Abdelhak H. Louzier J. Timm Recombinant BCG expressing the leishmania surface antigen Gp63 indices protective immunity against Leishmania major infection in BALB/mice Microbiology 141 1995 1585
2. Abou-Zeid C. Gares M.-P. J. Inwald Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae Infect Immun 65 1997 1856
3. C. Abou-Zeid I. Smith J.M. Grange The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies J Gen Microbiol 134 1988 531
4. P. Andersen Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins Infect Immun 62 1994 2536
5. P. Andersen Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis Scand J Immunol 45 1997 115
6. P. Andersen A.B. Andersen A.E. Sørensen S. Nagni Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice J Immunol 154 1995 3359
7. J.D. Aronson C.F. Aronson H.C. Taylor A twenty year appraisal of BCG vaccination in the control of tuberculosis Arch Intern Med 101 1958 881
8. S. Baldwin Evaluation of new vaccines against tuberculosis in the mouse and guinea pig model Infect Immun, 66 1998 2951
9. G.J. Bancroft R.D. Schreiber E.R. Unanue Natural immunity: A T-cell independent pathway of macrophage activation, defined in the scid mouse Immunol Rev 124 1991 5
10. F.C. Bange A.M. Brown W.R. Jacobs Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages Infect Immun 64 1996 1794
11. S. Bardarov J. Kriakov C. Carriere Conditionally replicating mycobacteriophages: A system for transposon delivery to Mycobacterium tuberculosis Proc Natl Acad Sci U S A 94 1997 10961
12. E.M. Beckman A. Medián S.M. Behar CD1c restricts responses of mycobacteria-specific T cells: Evidence for antigen presentation by a second member of the human CD1 family J Immunol 157 1996 2795
13. E.M. Beckman S.A. Porcelli C.T. Morita Recognition of a lipid antigen by CD1-restrcited αβ+ T cells Nature 372 1994 691
14. A. Bendelac CD1: Presenting unusual antigens to unusual T lymphocytes Science 269 1995 185
15. A. Bendelac Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes J Exp Med 182 1995 2091
16. A. Bendelac N. Killeen D.R. Littman R.H. Schwartz A subset of CD4+ thymocytes selected by MHC class I molecules Science 263 1994 1774
17. A. Bendelac O. Lantz M.E. Quimby CD1 recognition by mouse NK1+ T lymphocytes Science 268 1995 863
18. V.L. Bonata V.M.F. Lima R.E. Tascon Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis -infected mice Infect Immun 66 1998 169
19. R.F. Breiman M.A. Horwitz Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge: A model for studying host defense against lung infections caused by intracellular pathogens J Exp Med 165 1987 799
20. D. Chatterjee A.D. Roberts K. Lowell Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor Infect Immun 60 1992 1249
21. J.D. Cirillo C.K. Stover B.R. Bloom Bacterial vaccine vectors and Bacillus Calmette-Guerin Clin Infect Dis 20 1995 1001
22. J.W. Conlan A. Baskerville L.A. Ashworth Separation of Legionella pneumophila proteases and purification of a protease which produces lesions like those of Legionnaires' disease in guinea pig lung J Gen Microbiol 132 1986 1565
23. N. Connell C.K. Stover Jacobs W.R. Jr Old microbes with new faces: Molecular biology and the design of new vaccines Curr Opin Immunol 4 1992 442
24. P. Constant F. Davodeau Peyrat M.-A. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands Science 264 1994 267
25. A.M. Cooper D.K. Dalton T.A. Stewart Interleukin 12 [IL-12] is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis J Exp Med 186 1997 39
26. A.M. Cooper C. D'Souza A.A. Frank I.M. Orme The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms Infect Immun 65 1997 1317
27. A.M. Cooper J. Magram J. Ferrante I.M. Orme Disseminated tuberculosis in gamma interferon gene-disrupted mice J Exp Med 178 1993 2243
28. DiTirro J, et al: Disruption of the cellular inflammatory response to Listeria monocytogenes infection in gene-disrupted mice. Infect Immun, in press
29. C.D. D'Souza A.M. Cooper A.A. Frank An anti-inflammatory role for γδT lymphocytes in acquired immunity to Mycobacterium tuberculosis J Immunol 158 1997 1217
30. J.J. Donnelly J.B. Ulmer M.A. Liu DNA vaccines Life Sci 60 1997 163
31. L.A. Dreyfus B.H. Iglewski Purification and characterization of an extracellular protease of Legionella pneumophila Infect Immun 51 1986 736
32. D.F. Enarson J.F. Murray Global epidemiology of tuberculosis Rom W.N. Garay S. Tuberculosis 1995 Little Brown and Company New York
33. J.L. Flynn J. Chan K.J. Triebold An essential role for IFN-γ in resistance to M. tuberculosis infection J Exp Med 178 1993 2249
34. J.L. Flynn M.M. Goldstein K.J. Triebold Major histocompatibility complex class I restricted T cells are required for resistance to Mycobacterium tuberculosis infection Proc Natl Acad Sci U S A 89 1992 12013
35. J.M. Grange J. Gibson T.W. Osborn What is BCG? Tubercle 64 1983 129
36. J.P. Griffin K.V. Harshan W.K. Born I.M. Orme Kinetics of accumulation of γδ receptor-bearing T lymphocytes in mice infected with live mycobacteria Infect Immun 59 1991 4263
37. J.P. Griffin I.M. Orme Evolution of CD4 T cell subsets in naive and memory immune mice infected with Mycobacterium tuberculosis Infect Immun 62 1994 1683
38. Guleria I. Gares M.-P. J. Inwald Auxotrophic vaccines for tuberculosis Nat Med 2 1996 334
39. M.S. Hanson G.P. Bansal S. Langermann Efficacy and safety of live recombinant BCG vaccines Dev Biol Stand 84 1995 229
40. Horwitz M.A. Lee B.-W.E. B.J. Dillon G. Harth Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis Proc Natl Acad Sci U S A 92 1995 1530
41. R.D. Hubbard C.M. Flory F.M. Collins Immunization of mice with mycobacterial culture filtrate proteins Clin Exp Immunol 87 1992 92
42. R.E. Huebner Bacillus of Calmette and Guerin (BCG) vaccine Rom W.N. Garay S. Tuberculosis 1996 Little Brown and Company New York
43. K. Huygen J. Content O. Denis Immunogenicity and protective efficacy of a tuberculosis DNA vaccine Nat Med 2 1996 893
44. Jacobs W.R. Jr Advances in mycobacterial genetics: New promises for old diseases Immunobiology 184 1992 147
45. Jacobs W.R. Jr S.B. Snapper L. Lugosi B.R. Bloom Development of BCG as a recombinant vaccine vehicle Curr Top Microbiol Immunol 155 1990 153
46. C.R. Janway Frontiers in the immune response Nature 333 1988 804
47. E.M. Janis S.H.E. Kaufmann R.H. Schwartz D.M. Pardoll Activation of γδ T cells in the primary immune response to Mycobacterium tuberculosis Science 244 1989 713
48. C.M. Johnson A.M. Cooper A.A. Frank I.M. Orme Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis -infected mice with a disruption in the intracellular adhesion molecule 1 gene Infect Immun 66 1998 1666
49. D. Julien L. Brossay P.A. Sieling CD1: Clues on a new antigen-presenting pathway Res Immunol 147 1996 321
50. C.H. Ladel C. Blum A. Dreher Protective role of γδ T cells and αβ T cells in tuberculosis Eur J Immunol 25 1995 2877
51. C.H. Ladel C. Blum S.H.E. Kaufmann Control of natural killer cell-mediated innate resistance against the intracellular pathogen Listeria monocytogenes by γδT lymphocytes Infect Immun 64 1996 1744
52. P. Laochumroonvorapong J. Wang Lin C.-C. Perforin, a cytotoxic molecule with mediates cell necrosis, is not required for the early control of mycobacterial infection in mice Infect Immun 65 1997 127
53. D.B. Lowrie P.S. Jackett N.A. Ratcliffe Mycobacterium microti may protect itself from intracellular destruction by releasing cyclic AMP into phagosomes Nature 254 1975 600
54. D.B. Lowrie C.L. Silva M.J. Colston Protection against tuberculosis by a plasmid DNA vaccine Vaccine 15 1997 834
55. D.B. Lowrie R.E. Tascon C.L. Silva Vaccination against tuberculosis Int Arch Allergy Immunol 108 1995 309
56. E. Lozes K. Huygen J. Content Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex Vaccine 15 1997 830
57. G.B. Mackaness The induction and expression of cell-mediated hypersensitivity in the lung Am Rev Respir Dis 104 1971 813
58. A.S. Malin D.B. Young Designing a vaccine for tuberculosis BMJ 312 1996 1495
59. R.A. McAdam T.R. Weisbrod J. Martin In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis Infect Immun 63 1995 1004
60. D.N. McMurray Guinea pig model of tuberculosis Bloom B.R. Tuberculosis; Pathogenesis, Protection, and Control 1994 ASM Press Washington, DC
61. A. Melian E.M. Beckman S.A. Porcelli M.B. Brenner Antigen presentation by CD1 and MHC-encoded class I-like molecules Curr Opin Immunol 8 1996 82
62. P. Mombaerts J. Arnoldi F. Russ Different roles of αβ and γδ T cells in immunity against an intracellular bacterial pathogen Nature 365 1993 53
63. D.L. Montgomery K. Huygen A.M. Yawman Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNA Cell Mol Biol 43 1997 285
64. D.B. Moody B.B. Reinhold M.R. Guy Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells Science 278 1997 283
65. P.J. Murray A. Aldovini R.A. Young Manipulation and potentiation of anti-mycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines Proc Natl Acad Sci U S A 93 1996 934
66. M.A. O'Donnell A. Aldovini R.B. Duba Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes Infect Immun 62 1994 2508
67. I.M. Orme Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection J Immunol 140 1988 3589
68. I.M. Orme Evidence for a biphasic memory T cell response to high dose BCG vaccination in mice Tubercle 69 1988 125
69. I.M. Orme Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance, in mice inoculated with nonliving mycobacterial vaccines Infect Immun 56 1988 3310
70. I.M. Orme The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis J Immunol 138 1987 293
71. I.M. Orme F.M. Collins Cross protection against nontuberculous mycobacterial infections by Mycobacterium tuberculosis memory immune T lymphocytes J Exp Med 163 1986 203
72. Orme IM, Cooper AM: Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today, in press
73. I.M. Orme D.N. McMurray The immune response to tuberculosis in animals Rom W.N. Garay S. Tuberculosis 1996 Little Brown and Company New York 269
74. I.M. Orme E.S. Miller A.D. Roberts T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection J Immunol 148 1992 189
75. I.M. Orme R.W. Stokes F.M. Collins Only two out of fifteen BCG strains follow the BCG pattern Skamene E. Genetic Control of Host Resistance to Infection and Malignancy 1985 Alan R Liss New York 285
76. P.G. Pal M.A. Horwitz Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis Infect Immun 60 1992 4781
77. V. Pelicic M. Jackson Reynot J.-M. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis Proc Natl Acad Sci U S A 94 1997 10955
78. K. Pfeffer B. Schoel H. Bulle Primary responses to human T cells to mycobacteria: A frequent set of γδ T cells are stimulated by protease-resistant ligands Eur J Immunol 20 1990 1175
79. S.A. Porcelli The CD1 family: A third lineage of antigen-presenting molecules Adv Immunol 59 1995 1
80. S.A. Porcelli R.L. Modlin CD1 and the expanding universe of T cell antigens J Immunol 155 1995 3709
81. J.G. Prior A.A. Khan K.A. Cartwright Immunotherapy with Mycobacterium vaccae combined with second line chemotherapy in drug-resistant abdominal tuberculosis J Infect 31 1995 59
82. E.R. Rhoades A.M. Cooper I.M. Orme Chemokine response in mice infected with Mycobacterium tuberculosis Infect Immun 63 1995 3871
83. E.R. Rhoades A.A. Frank I.M. Orme Progression of pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis Tuber Lung Dis 78 1997 57
84. T.I. Roach D. Chatterjee J.M. Blackwell Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: Regulation of KC expression in murine macrophages by Lsh/Ity/Bcg Infect Immun 62 1994 1176
85. A.D. Roberts M.G. Sonnenberg D.J. Ordway Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis Immunology 85 1995 502
86. L. Rodrigues P.G. Smith Tuberculosis in developing countries and methods for its control Trans R Soc Trop Med Hyg 84 1990 739
87. B. Schoel S. Sprenger S.H.E. Kaufmann Phosphate is essential for stimulation of Vg9Vd2 T lymphocytes by mycobacterial low molecular weight ligand Eur J Immunol 24 1994 1886
88. P.A. Sieling D. Chatterjee S.A. Porcelli CD1-restricted T cell recognition of microbial lipoglycan antigens Science 269 1995 227
89. S. Stenger R.J. Mazzaccaro K. Uyemura Differential effects of cytolytic T cell subsets on intracellular infection Science 276 1997 1684
90. J.A.C. Sterne L.C. Rodrigues I.N. Guedes Does the efficacy of BCG decline with time since vaccination Int J Tuberc Lung Dis 2 1998 200
91. C.K. Stover G.P. Bansal M.S. Hanson Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: A candidate Lyme disease vaccine J Exp Med 178 1993 197
92. Stover C.K. de la Cruz V.F. G.P. Balsal Use of recombinant BCG as a vaccine delivery vehicle Adv Exp Med Biol 327 1992 175
93. Y. Tanaka C.T. Morita Y. Tanaka Natural and synthetic non-peptide antigens recognized by human γφ T cells Nature 375 1995 155
94. R.E. Tascon M.J. Colston S. Ragno Vaccination against tuberculosis by DNA injection Nat Med 2 1996 888
95. S.P. Tripathy Fifteen-year follow-up of the Indian BCG prevention trial Bull Int Union Tubercle Lung Dis 62 1987 69
96. J.B. Ulmer R.R. Deck C.M. DeWitt Induction of immunity by DNA vaccination: Application to influenza and tuberculosis Behring Inst Mitt 98 1997 79
97. J.B. Ulmer M.A. Liu D.L. Montgomery Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccination Vaccine 15 1997 792
98. E. Wiegeshaus V. Balasubramanian D.W. Smith Immunity to tuberculosis from the perspective of pathogenesis Infect Immun 57 1989 3671
99. N. Winter M. Lagranderie S. Gangloff Recombinant BCG strains expressing the SIVmac251 nef gene indice proliferative and CTL responses against nef synthetic peptides in mice Vaccine 13 1995 741
100. S. Xu A. Cooper S. Sturgill-Koszyncki Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium -infected macrophages J Immunol 153 1994 2568
101. D.B. Young TB Research entering the post-genomic era Mol Med Today 3 1997 6